https://www.avient.com/news/polyone-announces-20-increase-quarterly-dividend
+1 440-930-1018 +1 440-930-3162
https://www.avient.com/investor-center/news/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance
July 1, 2020 Attachment 1 1)
https://www.avient.com/investor-center/news/avient-expands-sustainable-solutions-portfolio-acquisition-magna-colours-ltd
July 1, 2021 July 1, 2021 Rose, Vice President, Corporate Communications, Avient Corporation, +1 440-930-3162, kyle.rose@avient.com
https://www.avient.com/investor-center/news/avient-completes-acquisition-dsm-protective-materials-dyneema
September 1, 2022 Sept. 1, 2022 Rose, Vice President, Corporate Communications, Avient Corporation, +1 440-930-3162, kyle.rose@avient.com
https://www.avient.com/resources/safety-data-sheets?page=5558
MC-61789PP ORANGE Q100-2-1 5YR UV 831397 MC-61790PP ORANGE Q080-2-1 5YR UV 831398 MC-73401PP WHITE W/ 1 YR UV
https://www.avient.com/news/specialty-and-sustainable-healthcare-material-solutions-avient-medtec-china-2023
June 1, 2023 Like other Mevopur formulations, they are manufactured in dedicated ISO 13485 facilities and supported by testing to ISO 10993-1, USP, European Pharmacopeia, and ICH Q3D guidelines. Avient will exhibit at Medtec China 2023 at the Suzhou International Expo Center in Hall C1, Stand V402, on June 1-3, 2023.
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2024-results
1) 1) 1)
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2019-results
Attachment 1 Special items (1) 1)
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2018-results
per share (see Attachment 1). Attachment 1 Special items (1)
https://www.avient.com/contact-0?area_of_inquiry=polymer colorants
1-866-737-2066 Find Your Local Office
